Targeted drug delivery system, Sem-VII, As per PCI Syllabus

AkshataJain17 1,836 views 30 slides Oct 16, 2024
Slide 1
Slide 1 of 30
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30

About This Presentation

Targeted drug delivery implies for selective
and effective localization of pharmacologically
active moiety at pre-selected target(s)
therapeutic in concentration.


Slide Content

Concept of targeted drug delivery
•The concept of targeted drug delivery system
given by "Paul Ehrlich", proposed drug
delivery as a "magic bullet“.
•Targeted drug delivery implies for selective
and effective localization of pharmacologically
active moiety at pre-selected target(s)
therapeutic in concentration.
•It restrict the entry of drug in non-targeted
cells, thus minimizing toxic effects.

Ideal characteristics of TDDS

Advantages

Disadvantages
• Rapid clearance of targeted systems.
• Immune reactions against intravenous administered carrier
systems.
• Insufficient localization of targeted systems into tumour cells.
• Diffusion and redistribution of released drugs.
• Requires highly sophisticated technology for the formulation.
• Requires skill for manufacturing storage, administration.
•Drug deposition at the target site may produce toxicity symptoms.
• Difficult to maintain stability of dosage form.
• Drug loading is usually law.

Components of Targeted Drug Delivery
System
Components Purpose
The active moiety To achieve the therapeutic
effect.
The carrier system (which
can be either soluble or
particulate)
To effect a favorable
distribution of the drug.
To protect the drug from
metabolism.
To protect the drug from
early clearance.
A "homing device“ To specifically target the
drug to the target cells or
target tissue

Carrier or Markers
•Targeteddrugdeliverycanbeachievedbyusing
carriersystem.
•Carrierisoneofthespecialmoleculeorsystem
essentiallyrequiredforeffectivetransportationof
loadeddruguptothepre-selectedsites.
•Theyareengineeredvectors,whichretaindrug
insideorontothemeitherviaencapsulationand/
orviaspacermoietyandtransportordeliverit
intovicinityoftargetcell.

Carrier System Used For Targeted Drug Delivery
Colloidal Carriers
Vesicular system:
Liposomes
Niosomes
Virosomes
Immunoliposomes
Microparticulatesystem:
•Microspheres
•Nanoparticles
Cellular Carriers
•Resealed erythrocytes
•Serum albumin
•Antibodies
•Platelets Leukocytes
Macro molecular Carriers
•Proteins,
•Glycoprotein,
•Neo-glycoprotein
•Polysaccharides

Types of targeted drug delivery system
•NanoTubes:
Theyarehollowcylindermadeofcarbon,atomswhich
canbefilledandsealedforpotentialdrugdelivery.

Nano shells
Nanoshellsarehollowsilicaspherescoveredwithgold.
Scientistscanattachantibodiestotheirsurfaces,
enablingtheshellstotargetcertainshellssuchas
cancercells.Absorptionoflightbynanoshellscreates
anintenseheatthatislethaltocells.

Gold Nano
ParticleScientistusesgoldnanoparticletodevelop
ultrasensitivedetectionsystemforDNAand
proteinmarkersassociatedwithmanyformsof
cancer,includingbreast,prostratecancer.

Dendrimers
Dendrimerspreciselydefined,syntheticnanoparticles
thatareapproximately510nmindiameter.Theyare
madeupoflayersofpolymersurroundingacontrolcore.
Thedendrimerssurfacecontainsmanydifferentsitesto
whichdrugsmaybeattach.Dendrimershaveatree-like
structurewithmanybrancheswhereavarietyof
molecules,includingdrugscanbeattached.

Liposomes
Liposomesaresimplemicroscopicvesiclesinwhichanaqueous
volumeisentirelycomposedbymembraneoflipidmolecule
variousamphiphilicmoleculeshavebeenusedtoform
liposomes.Thedrugmoleculescaneitherbeencapsulatedin
aqueousspaceorintercalatedintothelipidbilayersTheextent
oflocationofdrugwilldependuponitsphysico-chemical
characteristsandcompositionoflipids.

Niosomes
Niosomesarenonionicsurfactantvesicleswhichcan
entrapbothhydrophilicandlipophilicdrugseitherin
aqueousphaseorinvesicularmembranemadeupoflipid
materialsItisreportedtoattainbetterstabilitythan
liposome's.Itmayproveveryusefulfortargetingthe
drugsfortreatingcancer,parasitic,viralandother
microbialdiseasemoreeffectively.

Virosomes
•Virosomesareimmunemodulatingliposomes
consistingofsurfaceglycoproteinofinfluenzavirus
(immunestimulatingreconstitutedinfluenzavirosome)
muramyldipeptideetc.
•Virosomesmustbetargetorientedandtheirfusogenic
characteristicscouldbeexploitedingenomegrafting
andcellular.

Nano robots
•Nanoroboticsisthetechnologyofcreating
machinesorrobotsatorclosetothemicroscopic
scaleofananometre(10-meters).
•Morespecifically,Nanoroboticsreferstothestill
largelyhypotheticalnanotechnologyengineering
disciplineofdesigningandbuilding.

Monoclonal Antibodies
Thesearehomogenouspreparationsofantibodies
(orfragmentsofantibodies)inwhichevery
antibodyintheproductisidenticalinitsprotein
sequence,andthuseveryantibodyisexpectedto
havethesameantigenrecognitionsite,affinity,
biologicinteractions,anddownstreambiologic
effects.

Preparation of Monoclonal Antibodies
•MonoclonalAntibodyproductionormAbisproduced
bycelllinesorclonesobtainedfromtheimmunized
animalswiththesubstancestobestudied.Celllines
areproducedbyfusingB-cellsfromtheimmunized
animalwithmyelomacells.
•ToproducethedesiredmAB,thecellsmustbegrown
ineitheroftwoways:byinjectionintotheperitoneal
cavityofasuitablypreparedmouse(invivomethod)or
byinvitrotissueculture.
•Thevitrotissuecultureisthemethodusedwhenthe
cellsareplacedincultureoutsidethemousethe
mouse'sbodyinflask.

Practical steps for production
1.Immunize animal
2.Isolate spleen cells (containing antibody-producing B cell)
3.Fuse spleen cells with myeloma cell (using PEG)
4.Allow unfusedB cell to die
5.Add aminopterinto culture and kill unfusedmyeloma cells
6.Clone remaining cells (place 1 cell/well and allow each cell
to grow into a clones of cell)
7.Screen supernatant of each clone for presence of desired
antibody
8.Grow chosen clone of cells in tissue culture indefinitely
9.Harvest antibody from the culture.
10.$ 1000-2000 per mg

Applications
Major Applications:
(1) Diagnostic Applications
•Biochemical analysis
•Diagnostic Imaging
(2) Therapeutic Applications
• Direct use of MAbsas therapeutic agents
• MAbsas targeting agents.
(3) Protein Purification

1a. Biochemical analysis
•Routinelyusedinradioimmunoassay(RIA)and
enzyme-linkedimmunosorbentassays(ELISA)inthe
laboratory.
•Theseassaysmeasurethecirculatingconcentrationsof
hormones(insulin,humanchorionicgonadotropin,
growthhormone,progesterone,thyroxine,
triiodothyronine,thyroidstimulatinghormone)and
severalothertissueandcellproducts(bloodgroup
antigens,bloodclottingfactors,interferon's,
interleukins,tumormarkers).

1b. Diagnostic imaging
•Radiolabeled-MAbsareusedinthediagnosticimaging
ofdiseases,andthistechniqueisreferredtoas
immunoscintigraphy.Theradioisotopescommonly
usedforlabelingMAbareiodine-131andtechnetium-
99.TheMAbtaggedwithradioisotopeareinjected
intravenouslyintothepatients.
•TheseMAbslocalizeatspecificsites(sayatumor)
whichcanbedetectedbyimagingtheradioactivity.In
recentyears,singlephotonemissioncomputed
tomography(SPECT)camerasareusedtogiveamore
sensitivethreedimensionalappearanceofthespots
localizedbyradiolabeled-MAbs.
•Myocardialinfarction,DVT,atherosclorosisetc.

2a.DirectuseofMAbsastherapeuticagents
•Indestroyingdisease-causing
organisms:MAbspromoteefficient
opsonizationofpathogenicorganisms(bycoatingwith
antibody)andenhancephagocytosis.
•Intheimmunosuppressionoforgantransplantation:
Inthenormalmedicalpractice,immunosuppressive
drugssuchascyclosporinandprednisoneare
administeredtoovercometherejectionoforgan
transplantation.Inrecentyears,MAbsspecifictoT-
lymphocytesurfaceantigensarebeingusedforthis
purpose.

2b. MAbsas targeting agents.
•ThedrugscanbecoupledwithMAb(directed
againstacellsurfaceantigenofthecells,saya
tumor)andspecificallytargetedtoreachthesite
ofaction.
•Eg.Alkalinephosphatasefortheconversionof
phosphatepro-drugs.
•Carboxypeptidaseforconvertinginactive
carboxylpro-drugstoactivedrugs.
•Lactamaseforhydrolyzingẞ-lactamring
containingantibiotics.

3. Protein Purification
•Monoclonalantibodiescanbeproducedforanyprotein.And
thesoproducedMAbcanbeconvenientlyusedforthe
purificationoftheproteinagainstwhichitwasraised.
•MAbscolumnscanbepreparedbycouplingthemtocyanogen
bromideactivatedSepharose(chromatographicmatrix).The
immobilizedMAbsinthismannerareveryusefulforthe
purificationofproteinsbyimmunoaffinitymethod.
•TherearecertainadvantagesofusingMAbsforprotein
purification.TheseincludethespecificityoftheMAbtobindto
thedesiredprotein,veryefficientelutionfromthe
chromatographiccolumnandhighdegreeofpurification.